nejm glp 1 Expanding Clinical Benefits for GLP-1–Receptor Agonists Dr - The NEJM just

Researchers have found that inflammatory cytokines induce the expression of COX-2 (a chief driver of pain and inflammation among many chronic diseases) in the osteoblasts (cells responsible for the synthesis and mineralization of bones) of inflamed joints

McDonalds, the worlds largest fast-food chain, claims that it has not yet seen an impact on their business due to GLP-1 drugs, but acknowledges that future impact is uncertain

Erastin exploits the defective mitophagy-driven ROS accumulation to circumvent the ferroptosis resistance characteristic of EESCs, thereby enhancing its therapeutic efficacy

PF-06882961 is orally bioavailable and efficacious for lowering glucose and food intake in monkeys The pharmacokinetics of PF-06882961 were examined in rats and monkeys after intravenous (IV) and oral administration (Fig 5A, Table S7)